Status:
NOT_YET_RECRUITING
Comparison of Convective Water Vapor Ablation (Convective Water Vapor Energy, WAVE™) With the Rezum™ System Versus Holmium Laser Enucleation of the Prostate (HoLEP) Versus Bipolar Transurethral Resection of the Prostate (TUR-P) in Patients With Benign Prostatic Syndrome (BPS) - A Randomized Study
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Österreichische Gesellschaft für Urologie
Conditions:
BPH (Benign Prostatic Hyperplasia)
HoLEP
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
Benign prostatic enlargement (BPH/BPS) is one of the most common benign diseases in adult men. About 50% of men are affected by the age of 50, and between the ages of 70 and 80 the prevalence rises to...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patients with confirmed benign prostatic syndrome for whom surgical therapy is indicated
- Prostate volume between 30 and 80 ml
Exclusion
- Lack of capacity to give informed consent
- Emergency surgeries
- Known prostate carcinoma
- Elevated post-void residual urine \> 300 ml
- Neurogenic bladder emptying disorder
- Urethral pathologies
- High-intensity anticoagulation
- Dual antiplatelet therapy
- History of pelvic radiation
- Chronic pelvic pain syndrome
Key Trial Info
Start Date :
November 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2030
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT07204002
Start Date
November 15 2025
End Date
October 15 2030
Last Update
November 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.